EP in D2B? A Journal Club Recap
August 17th, 2010 at 1:42 am by NickThe topic for Journal Club on August 4, 2010 was STEMI. We started by reviewing the history behind the current treatment of MI patients. Then we talked briefly about the FDNY Protocols, which include notifying the receiving hospital of an inbound STEMI pt & faxing a copy of the EKG to that hospital.
Then we discussed the background article entitled “Emergency Department Activation of an Interventional Cardiology Team Reduces Door-to Balloon Times in ST-Segment-Elevation Myocardial Infarction”. This was a study led by Dr Singer out of Stony Brook University. It was a before-and-after trial in a suburban academic medical center with 500 beds and 75,000 annual ED visits to compare DTB times in pts w/STEMI before and after implementation of a “code H” protocol. They used a consecutive sample of pts presenting to the ED with EKG and clinical evidence of STEMI within 30 minutes of arrival during 2 similar 24-month periods, before and after implementation of the code H protocol. This protocol included: 1) EPs activating the cath lab via a single call to a central page operator, 2) ED activating the cath lab while the pt is en route to the hospital, 3) Expecting the cath lab staff to arrive within 20 minutes, & 4) Having ED and cath lab staff use real-time data feedback. The primary outcome was door-to-balloon (DTB) time. They had 97 total pts, 43 before and 54 after the implementation of the code H protocol. Implementation of the code H protocol reduced the median DTB time by 68 min (p<.001) and increased the proportion of pts undergoing PCI within 90 minutes from 2.8% to 29%. If you look at it in terms of risk of missing the 90-min D2B mark, the absolute risk reduction (ARR) was 26% and you’d need to treat (NNT) 3.85 pts under “Code H” to expect one more makes it in under 90 min. They concluded that “the greatest opportunity for improvement is in reducing the time from cardiology arrival to the bedside and initiation of the percutaneous coronary intervention. Equally important is the need to engage all health care providers involved in the treatment of patients with ST-segment-elevation myocardial infarction.”
The 2nd paper, entitled “Impact of the Prehospital ECG on Door-to-Balloon Time in ST Elevation Myocardial Infarction”by Rao, et al. out of SE Michigan was a prospective, observational study conducted in 3 hospitals from Oct 2003-April 2008. (They had no conflicts of interest.) During the trial, EMS 12L EKGs were transmitted to the ED & the cath lab was activated “as soon as the ED physician diagnosed STEMI”. The control group included all patients who came to the ED during the same time period via EMS w/o prehospital EKGs or as walk-ins. The primary endpoint was DTB time and secondary endpoints included time of admission, cardiac risk factors, LOS (length of stay), and infarct-related arteries. They found that pts who had a prehospital ECG had a mean DTB time of 60.2 minutes, compared to 90.5 minutes in pts with in-hospital ECGs.(ARR=30%, NNT=3.33pts). No pts in the prehospital ECG group died but there was a 2% mortality rate in the control group.
Some questions we asked about this study included:
- 3 centers with different time periods (Hospital A had 386 pts between 10/03 & 4/08 but only 18 prehospital ECGs. Hospitals B&C had 89 & 134 pts, respectively, between 3/07 & 4/08, with 40 & 50 prehospital ECGs, respectively.)
- Why did hospital A have 386 pts but only 18 w/ prehospital ECGs?
- W hy were hospitals B&C only involved at the end of the study?
- They did not reveal enough data about their control pts. Were they STEMI pts? Did they have chest pain or CP equivalent symptoms? Etc.
- ~50% of pts had a R-sided MI, which seems like a high number. However, they had no deaths in the prehospital group but the majority of pts had non-LAD lesions, which speaks well of their data.
- They concluded there were no differences in LOS between the groups, yet the in-hospital deaths had LOS of 3.5 days +/- 3.2 (i.e. ~0-7 days), which seems like a wide range.
- There was a significant difference in the data of African American pts, which they attributed to these mostly being seen at an inner-city hospital which didn’t get a machine to receive EMS ECGs until late in the study. However, they did not show age- & race-matched data sets to account for these differences.
The final paper by Steg et al. out of France (cardiologists who are affiliated with Sanofi-Aventis) was entitled “Bypassing the Emergency Room Reduces Delays and Mortality in ST Elevation Myocardial Infarction: the USIC 2000 Registry”. This registry was a prospective registry of all pts admitted to ICUs in France for AMI by the end of 2000. The study included all consecutive pts admitted from November 1-30, 2000 with a confirmed diagnosis of STEMI who were admitted within 12 hours of the onset of symptoms. 1204 of 1922 pts met criteria for inclusion in the study. Of these, 66.9% were admitted directly to the CCU or cath lab, as mobile ICUs in France are staffed by physicians who decide where the pt goes. 33.1% were admitted via the ED & these pts were sicker based on TIMI score & Killip Class. 787 pts (65.4%) received reperfusion, including primary PCI and thrombolysis (both prehospital & in hospital). All-cause mortality at day 5 was 4.9% in pts admitted directly to CCU and 8.6% in those admitted via the ED. (ARR=3.7%, NNT=27pts) More ED pts (35%) received lytics and they received them later than the 30% of CCU pts who received them. However, the authors did not account for this in their results.
Some issues that came up in discussing this study:
- The French EMS system is different from the US system (ED MDs on Mobile ICUs)
- Conflicts of interest (Sanofi)
- Only ran study for 1 month. Why that one?
- Data from 2000, before we knew lytics prior to PCI was bad.
- Didn’t explain why pts went to ED vs CCU
- Some pts went directly to the cath lab but had no PCI, which wasn’t explained.
- They also didn’t explain why the mortality was so much higher than we would expect.
They concluded that “bypassing the ER was associated with an apparent substantial survival benefit at both five days and one year compared with patients admitted via the ER. These findings of shorter delays and improved survival suggest that pathways should be established for patients with STEMI to bypass the ER.” However, was it really the ER that was the problem, or was it a delay in treatment?
In conclusion, as stated in the Singer article, “to be successful at reducing door-to-balloon times, we must develop strategies that reduce all the intervals that make up the process of treating patients with ST-segment-elevation myocardial infarction. Thus, the best-performing hospitals have improved each of the key components that make up the overall process of care, including door-to-ECG, ECG-to-laboratory, and laboratory-to-balloon times.”
Posted in Journal Club, ACS, Blog | No Comments »